GeneDx Holdings Corp
WGS126.360USD
+3.480+2.83%
Cierre 08/15, 16:00（ET）Cotizaciones retrasadas 15 min
3.63BCap. mercado
PérdidaP/E TTM
Más Datos de GeneDx Holdings Corp Compañía
GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. GeneDx utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. GeneDx provides a variety of genetic diagnostic tests, screening solutions, and information. The Legacy Sema4 diagnostics segment provides reproductive and women's health and somatic oncology diagnostic testing and screening products.
Información de la empresa
Símbolo de cotizaciónWGS
Nombre de la empresaGeneDx Holdings Corp
Fecha de salida a bolsaSep 04, 2020
Director ejecutivoMs. Katherine A. Stueland
Número de empleados1000
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 04
Dirección333 Ludlow Street
CiudadSTAMFORD
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal06902
Teléfono18887291206
Sitio Webhttps://sema4.com/
Símbolo de cotizaciónWGS
Fecha de salida a bolsaSep 04, 2020
Director ejecutivoMs. Katherine A. Stueland
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+6.12%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+63.87%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
20.13K
+179.38%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
4.12K
-54.90%
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+6.12%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+63.87%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
20.13K
+179.38%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
4.12K
-54.90%
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Patients with third party insurance
68.06M
78.13%
Institutional customers
17.60M
20.21%
Other
1.36M
1.56%
Self pay patients
96.00K
0.11%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Patients with third party insurance
68.06M
78.13%
Institutional customers
17.60M
20.21%
Other
1.36M
1.56%
Self pay patients
96.00K
0.11%
Estadísticas de accionistas
Actualizado: hace 2 horas
Actualizado: hace 2 horas
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Casdin Capital, LLC
12.21%
Corvex Management LP
10.65%
William Blair Investment Management, LLC
5.68%
Icahn School of Medicine at Mount Sinai
4.78%
OPKO Health Inc
4.77%
Otro
61.91%
Accionistas
Accionistas
Proporción
Casdin Capital, LLC
12.21%
Corvex Management LP
10.65%
William Blair Investment Management, LLC
5.68%
Icahn School of Medicine at Mount Sinai
4.78%
OPKO Health Inc
4.77%
Otro
61.91%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
34.86%
Hedge Fund
34.61%
Investment Advisor/Hedge Fund
32.44%
Corporation
10.71%
Research Firm
5.56%
Individual Investor
1.75%
Pension Fund
1.22%
Bank and Trust
0.42%
Sovereign Wealth Fund
0.29%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
397
34.23M
119.24%
+1.02M
2025Q1
398
32.79M
115.46%
-47.86K
2024Q4
341
29.17M
104.22%
+1.72M
2024Q3
289
26.18M
97.50%
+377.48K
2024Q2
262
24.98M
95.33%
+588.25K
2024Q1
260
22.13M
86.19%
+1.41M
2023Q4
271
20.57M
80.67%
-567.28K
2023Q3
283
21.68M
85.29%
-751.02K
2023Q2
291
21.85M
86.03%
-864.88K
2023Q1
296
21.58M
684.27%
+3.47M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Casdin Capital, LLC
3.53M
12.36%
--
--
May 05, 2025
Corvex Management LP
2.91M
10.19%
+434.85K
+17.58%
May 05, 2025
William Blair Investment Management, LLC
1.19M
4.17%
+518.99K
+77.46%
Mar 31, 2025
Icahn School of Medicine at Mount Sinai
1.37M
4.81%
-1.35M
-49.50%
Feb 21, 2025
OPKO Health Inc
1.37M
4.8%
-800.83K
-36.88%
Nov 20, 2024
BlackRock Institutional Trust Company, N.A.
1.04M
3.64%
-41.94K
-3.89%
Mar 31, 2025
The Vanguard Group, Inc.
1.03M
3.6%
+23.46K
+2.34%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
503.73K
1.77%
+503.73K
--
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: mié., 6 de ago
Actualizado: mié., 6 de ago
Nombre
Proporción
Global X Genomics & Biotechnology ETF
3.13%
Innovator IBD 50 Fund ETF
3.09%
SPDR S&P Health Care Services ETF
2.64%
Harbor Health Care ETF
1.75%
Franklin Genomic Advancements ETF
1.19%
Simplify Health Care ETF
1.03%
Hypatia Women CEO ETF
0.78%
Fidelity Enhanced Small Cap ETF
0.67%
First Trust Small Cap Growth AlphaDEX Fund
0.57%
First Trust Active Factor Small Cap ETF
0.51%
Ver más
Global X Genomics & Biotechnology ETF
Proporción3.13%
Innovator IBD 50 Fund ETF
Proporción3.09%
SPDR S&P Health Care Services ETF
Proporción2.64%
Harbor Health Care ETF
Proporción1.75%
Franklin Genomic Advancements ETF
Proporción1.19%
Simplify Health Care ETF
Proporción1.03%
Hypatia Women CEO ETF
Proporción0.78%
Fidelity Enhanced Small Cap ETF
Proporción0.67%
First Trust Small Cap Growth AlphaDEX Fund
Proporción0.57%
First Trust Active Factor Small Cap ETF
Proporción0.51%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Fecha
Tipo
Relación
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
